ZYUS Life Sciences Corporation announced that it will receive $1,484,600 in funding on February 16, 2023. The company will issue common shares and non-convertible debt in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 CAD | -1.92% | -1.92% | +13.33% |
05-07 | ZYUS Life Sciences Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04-23 | ZYUS Life Sciences Receives US Patent for Pain Management Drug Candidate | MT |
1st Jan change | Capi. | |
---|---|---|
+13.33% | 52.9M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- ZYUS Stock
- News ZYUS Life Sciences Corporation
- ZYUS Life Sciences Corporation announced a financing transaction